ALS Center

Dr. Mary Dedarous, principal investigator and medical director, ALS Center, speaks with a patient. The division is part of the Dr. Robert H. Harris Neuroscience Treatment Center at Hackensack Meridian Health's Jersey Shore University Medical Center in Neptune. - PROVIDED BY HACKESACK MERIDIAN HEALTH
Jan 29, 2024

HMH’s Jersey Shore ALS Center is nation’s 1st to offer clinical study

The DAZALS investigation from Corcept Therapeutics aims to evaluate the safety and efficacy of dazucorilant, an investigational treatment, in patients with amyotrophic lateral sclerosis, commonly known as Lou Gehrig's disease.

The team from the ALS Center at the Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center was honored during the ALS United Mid-Atlantic 2023 Annual Celebration on Nov. 10.
Nov 21, 2023

ALS chapter rebrands after legal separation from national organization

The facility at Hackensack Meridian Jersey Shore University Medical Center in Neptune belongs to the newly renamed ALS United Mid-Atlantic. 

Cutting the ribbon, from left, on the new ALS Center in spring 2023 are: Brian Walch, vice president of clinical operations, Jersey Shore University Medical Center; Jeff Cline, executive director, ALS Association; Steve Spaulding, director of care services, ALSA Greater Philadelphia Chapter; Dr. Mary Sedarous, ALS Center medical director; Ellen Anne Gall, ALS Center; Dr. Alan Colicchio, chair of neurology, JSUMC, and medical director, Neuroscience Care Transformation Service, Hackensack Meridian Health, Southern Market; and Kathy Valentino, social worker with the Joan Dancy and PALS Foundation. - HACKENSACK MERIDIAN HEALTH
Jun 15, 2023

Hackensack Meridian’s ALS Center offers new treatment

The facility at the Jersey Shore University Medical Center can now provide patients with an injection that targets a genetic cause of Lou Gehrig’s Disease.